Post by wsucougarbill on Feb 9, 2024 18:17:26 GMT
Sounds like you should have requested to be on the call, as Bill and I did. Had you done so, you might have better insight, and be better informed vs speculating.
We posted as honest and detailed synopsis of the meeting, which lasted over an hour. I covered everything that I posted earlier, except for the part about Phil loaning the company the money, since he wasn’t on the call that seemed inappropriate.
You post about the breakup value of Opko a lot on yahoo, and even in your analysis you never used to mention iberoamerica, because they never talk about it. That little enterprise would be a veritable gold mine for the right PE firm, probably fetch $340m the high end of the value spectrum.
So that division is worth about 45% of our current market cap, and the street assigns the value at zero.
A really dynamic CEO and CFO would conspire together over a cup of coffee to say “suck it” to Wall Street, and capture its true value. If Phil is so fond of Hans that he can’t imagine a world without him spin the division off on the Madrid Exchange and have Opko retain 20%.
The minute they make the first such move the street will start looking to see what else Phil has in the storage closet that might have value.
I asked SR point blank if there was anything contractually with PFE preventing them from accessing the NGENLA revenue stream. He assured us there is not.
You know we covered the lab situation in detail. I didn’t bring it up earlier because Lux covered it. We questioned their 2X+ valuation and EZ gave us 2-3 comps, enough data points that I’m confident they can get that price for oncology and women’s health. They can just divvy up the footprint for the base business between the big 2 and be done.
But someone has to get off their ass and do something for any of this to matter.